These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17535758)

  • 1. [Calibrating the SCORE cardiovascular risk chart for use in Spain].
    Sans S; Fitzgerald AP; Royo D; Conroy R; Graham I
    Rev Esp Cardiol; 2007 May; 60(5):476-85. PubMed ID: 17535758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland.
    Marques-Vidal P; Rodondi N; Bochud M; Pécoud A; Hayoz D; Paccaud F; Mooser V; Waeber G; Vollenweider P
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):402-8. PubMed ID: 18677163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany.
    Hense HW; Koesters E; Wellmann J; Meisinger C; Völzke H; Keil U
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):409-15. PubMed ID: 18677164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consequences of using different methods to assess cardiovascular risk in primary care.
    Fornasini M; Brotons C; Sellarès J; Martinez M; Galán ML; Sáenz I; da Pena JM
    Fam Pract; 2006 Feb; 23(1):28-33. PubMed ID: 16243952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimating cardiovascular risk in Spain using different algorithms].
    Comín E; Solanas P; Cabezas C; Subirana I; Ramos R; Gené-Badía J; Cordón F; Grau M; Cabré-Vila JJ; Marrugat J
    Rev Esp Cardiol; 2007 Jul; 60(7):693-702. PubMed ID: 17663853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment].
    Buitrago F; Cañón-Barroso L; Díaz-Herrera N; Cruces-Muro E; Escobar-Fernández M; Serrano-Arias JM
    Rev Esp Cardiol; 2007 Feb; 60(2):139-47. PubMed ID: 17338879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway.
    Lindman AS; Veierød MB; Pedersen JI; Tverdal A; Njølstad I; Selmer R
    Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):501-7. PubMed ID: 17667638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Model for estimation of cardiovascular risk in Norway].
    Selmer R; Lindman AS; Tverdal A; Pedersen JI; Njølstad I; Veierød MB
    Tidsskr Nor Laegeforen; 2008 Jan; 128(3):286-90. PubMed ID: 18264151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality attributable to cardiovascular risk factors in Spain.
    Banegas JR; Rodríguez-Artalejo F; Graciani A; Villar F; Herruzo R
    Eur J Clin Nutr; 2003 Sep; 57 Suppl 1():S18-21. PubMed ID: 12947446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the SCORE and Wilson-Grundy methods for the assessment of cardiovascular risk in community pharmacies.
    Amariles P; Machuca M; Faus MJ; Baena MI; Martinez-Martinez F; Jimenez-Martin J
    J Clin Pharm Ther; 2008 Oct; 33(5):475-81. PubMed ID: 18834361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The risk of suffering a cardiovascular disease in the making of decisions. From evidence to the clinic].
    Villar Alvarez F; Maiques Galán A; Franch Taix M; Banegas Banegas JR; Vilaseca Canals J
    Med Clin (Barc); 1999; 112 Suppl 1():67-73. PubMed ID: 10618802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain. Pooled analysis of data from population-based epidemiological studies: the ERICE Study.
    Gabriel R; Alonso M; Segura A; Tormo MJ; Artigao LM; Banegas JR; Brotons C; Elosua R; Fernández-Cruz A; Muñiz J; Reviriego B; Rigo F;
    Rev Esp Cardiol; 2008 Oct; 61(10):1030-40. PubMed ID: 18817679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.
    Hallan S; Astor B; Romundstad S; Aasarød K; Kvenild K; Coresh J
    Arch Intern Med; 2007 Dec; 167(22):2490-6. PubMed ID: 18071172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of the absolute global cardiovascular risk: comparison between the risk chart and the individual score of the CUORE Project].
    Giampaoli S; Palmieri L; Donfrancesco C; Panico S; Pilotto L; Addis A; Boccanelli A; Di Pasquale G; Brignoli O; Filippi A; Vanuzzo D;
    G Ital Cardiol (Rome); 2006 May; 7(5):359-64. PubMed ID: 16752519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality.
    De Bacquer D; De Backer G
    Int J Cardiol; 2010 Sep; 143(3):385-90. PubMed ID: 19386372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tendencies in mortality from cardiovascular diseases in the Valencian community (1976-1992)].
    Bautista Rentero D; Pérez Hoyos S
    Rev Esp Cardiol; 1997 May; 50(5):308-13. PubMed ID: 9281009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fewer deaths from cardiovascular disease than expected from the Systematic Coronary Risk Evaluation chart in a Swedish population.
    Stenlund H; Lönnberg G; Jenkins P; Norberg M; Persson M; Messner T; Boman K; Pearson T; Wall S; Nyström L; Weinehall L
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):321-4. PubMed ID: 19357519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk assessment for informed decision making. Validity of prediction tools].
    Lenz M; Mühlhauser I
    Med Klin (Munich); 2004 Nov; 99(11):651-61. PubMed ID: 15583875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up].
    Guize L; Thomas F; Bean K; Benetos A; Pannier B
    Bull Acad Natl Med; 2007; 191(4-5):791-803; discussion 803-5. PubMed ID: 18225434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.